584 EVALUATION OF THE SAFETY AND IMMUNOGENICITY OF A NEW DTP VACCINE CONTAINING AN ACCELULAR PERTUSIS COMPONENT IN 4–6 YEAR OLD CHILDREN
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.
Details